HomeCompareDMKPQ vs QYLD

DMKPQ vs QYLD: Dividend Comparison 2026

DMKPQ yields 2000000.00% · QYLD yields 11.92%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 DMKPQ wins by $4.879226400974806e+39M in total portfolio value
10 years
DMKPQ
DMKPQ
● Live price
2000000.00%
Share price
$0.00
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$4.879226400974806e+39M
Annual income
$4,878,746,539,330,970,000,000,000,000,000,000,000,000,000,000.00
Full DMKPQ calculator →
QYLD
Global X Nasdaq 100 Covered Call ETF
● Live price
11.92%
Share price
$17.15
Annual div
$2.04
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$25.4K
Annual income
$5,659.31
Full QYLD calculator →

Portfolio growth — DMKPQ vs QYLD

📍 DMKPQ pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodDMKPQQYLD
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, DMKPQ + QYLD cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
DMKPQ pays
QYLD pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

DMKPQ
Annual income on $10K today (after 15% tax)
$170,000,000.00/yr
After 10yr DRIP, annual income (after tax)
$4,146,934,558,431,324,500,000,000,000,000,000,000,000,000,000.00/yr
QYLD
Annual income on $10K today (after 15% tax)
$1,013.51/yr
After 10yr DRIP, annual income (after tax)
$4,810.41/yr
At 15% tax rate, DMKPQ beats the other by $4,146,934,558,431,324,500,000,000,000,000,000,000,000,000,000.00/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of DMKPQ + QYLD for your $10,000?

DMKPQ: 50%QYLD: 50%
100% QYLD50/50100% DMKPQ
Portfolio after 10yr
$2.439613200487403e+39M
Annual income
$2,439,373,269,665,485,000,000,000,000,000,000,000,000,000,000.00/yr
Blended yield
99.99%
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

DMKPQ buys
0
QYLD buys
0
No recent congressional trades found for DMKPQ or QYLD in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricDMKPQQYLD
Forward yield2000000.00%11.92%
Annual dividend / share$2.00$2.04
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%0%
Portfolio after 10y$4.879226400974806e+39M$25.4K
Annual income after 10y$4,878,746,539,330,970,000,000,000,000,000,000,000,000,000,000.00$5,659.31
Total dividends collected$4.879195005460081e+39M$27.1K
Payment frequencyquarterlymonthly
SectorStockETF

Year-by-year: DMKPQ vs QYLD ($10,000, DRIP)

YearDMKPQ PortfolioDMKPQ Income/yrQYLD PortfolioQYLD Income/yrGap
1← crossover$200,010,700$200,000,000.00$10,352$1,192.36+$200.00MDMKPQ
2$3,738,731,768,458$3,738,517,757,009.35$10,830$1,347.57+$3738731.76MDMKPQ
3$65,315,062,866,930,490$65,311,062,423,938,240.00$11,460$1,539.07+$65315062866.92MDMKPQ
4$1,066,400,830,062,625,000,000$1,066,330,942,945,357,500,000.00$12,275$1,777.84+$1066400830062625.00MDMKPQ
5$16,272,182,796,453,826,000,000,000$16,271,041,747,565,660,000,000,000.00$13,323$2,078.95+$16272182796453826560.00MDMKPQ
6$232,054,240,113,661,900,000,000,000,000$232,036,828,878,069,680,000,000,000,000.00$14,667$2,463.34+$2.3205424011366188e+23MDMKPQ
7$3,092,799,066,104,688,500,000,000,000,000,000$3,092,550,768,067,767,400,000,000,000,000,000.00$16,396$2,960.57+$3.0927990661046884e+27MDMKPQ
8$38,524,105,697,352,694,000,000,000,000,000,000,000$38,520,796,402,351,967,000,000,000,000,000,000,000.00$18,631$3,612.97+$3.8524105697352695e+31MDMKPQ
9$448,468,826,014,798,700,000,000,000,000,000,000,000,000$448,427,605,221,702,600,000,000,000,000,000,000,000,000.00$21,548$4,482.15+$4.484688260147987e+35MDMKPQ
10$4,879,226,400,974,806,000,000,000,000,000,000,000,000,000,000$4,878,746,539,330,970,000,000,000,000,000,000,000,000,000,000.00$25,398$5,659.31+$4.879226400974806e+39MDMKPQ

DMKPQ vs QYLD: Complete Analysis 2026

DMKPQStock

DMK Pharmaceuticals Corporation, a clinical stage neuro-biotechnology company, develops and commercializes products in the therapeutic areas of allergy, opioid overdose, respiratory, and inflammatory diseases. The company's lead clinical stage product candidate, DPI-125, which is indicated for the treatment of opioid use disorder. Its products include SYMJEPI epinephrine injection for the emergency treatment of allergic reactions to stinging and biting insects, allergen immunotherapy, foods, drugs, diagnostic testing substances, and other allergens, as well as idiopathic or exercise-induced anaphylaxis; and ZIMHI naloxone injection for the treatment of opioid overdose. The company was formerly known as Adamis Pharmaceuticals Corporation and changed its name to DMK Pharmaceuticals Corporation in September 2023. The company is headquartered in San Diego, California. On February 2, 2024, DMK Pharmaceuticals Corporation, along with its affiliates, filed a voluntary petition for reorganization under Chapter 11 in the U.S. Bankruptcy Court for the District of Delaware.

Full DMKPQ Calculator →

QYLDETF

The Global X Nasdaq 100 Covered Call ETF (QYLD) seeks to provide investment results that correspond generally to the price and yield performance, before fees and expenses, of the Cboe Nasdaq-100 BuyWrite V2 Index.

Full QYLD Calculator →
📬

Get this DMKPQ vs QYLD comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

DMKPQ vs SCHDDMKPQ vs JEPIDMKPQ vs ODMKPQ vs KODMKPQ vs MAINDMKPQ vs XYLDDMKPQ vs JEPQDMKPQ vs RYLD

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.